Hong, Y., Casimir, M., Houghton, B. C., Zhang, F., Jensen, B., Omoyinmi, E., . . . Eleftheriou, D. (2022). Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2. Frontiers in Immunology, 13, 852830. doi:10.3389/fimmu.2022.852830

Garcia-Perez, L., van Eggermond, M., van Roon, L., Vloemans, S. A., Cordes, M., Schambach, A., . . . Pike-Overzet, K. (2020). Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID. Molecular Therapy - Methods and Clinical Development, 17, 666-682. doi:10.1016/j.omtm.2020.03.016

Rai, R., Romito, M., Rivers, E., Turchiano, G., Blattner, G., Vetharoy, W., . . . Cavazza, A. (2020). Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome. Nature Communications, 11 (1), 4034. doi:10.1038/s41467-020-17626-2

Zhang, Z. Y., Thrasher, A. J., & Zhang, F. (2019). Gene therapy and genome editing for primary immunodeficiency diseases. Genes and Diseases. doi:10.1016/j.gendis.2019.07.007

Poletti, V., Charrier, S., Corre, G., Gjata, B., Vignaud, A., Zhang, F., . . . Mavilio, F. (2018). Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency. Molecular Therapy - Methods and Clinical Development, 9, 257-269. doi:10.1016/j.omtm.2018.03.002

Zhang, F., Santilli, G., & Thrasher, A. J. (2017). Characterization of a core region in the A2UCOE that confers effective anti-silencing activity. Scientific reports, 7 (1), 10213. doi:10.1038/s41598-017-10222-3

Chandra, A., Zhang, F., Gilmour, K. C., Webster, D., Plagnol, V., Kumararatne, D. S., . . . Thrasher, A. J. (2016). Common variable immunodeficiency and natural killer cell lymphopenia caused by Ets-binding site mutation in the IL-2 receptor γ (IL2RG) gene promoter. Journal of Allergy and Clinical Immunology, 137 (3), 940-942.e4. doi:10.1016/j.jaci.2015.08.049

Charrier, S., Poletti, V., Martin, S., Gjata, B., Hebben, M., Vignaud, A., . . . Mavilio, F. (2016). Development of a Clinical Lentiviral Vector for Gene Therapy of SCID-X1. Presented at: 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT). doi:10.1016/S1525-0016(16)33498-0

Poletti, V., Corre, G., Charrier, S., Zhang, F., Buckland, K., Rothe, M., . . . Mavilio, F. (2016). Lentiviral vector integration site analysis in a preclinical study of ex-vivo gene therapy for SCID-X1. Presented at: Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy.

Charrier, S., Poletti, V., Martin, S., Vignaud, A., Hebben, M., Zhang, F., . . . Mavilio, F. (2015). Pre-clinical development of lentiviral gene therapy for SCID-X1. HUMAN GENE THERAPY, 26 (10), A60. MARY ANN LIEBERT, INC.